Feasibility of randomizing danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the danflu-1 trial

HIGHLIGHTS

• who: Niklas Dyrby Johansen from the Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark have published the research work: Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial, in the Journal: (JOURNAL) of September/17,/2021
• what: The study aims to include 40 000 paru2011 ticipants during the 2021/2022 influenza season. The study aims to integrate a pragmatic randomized trial into routine vaccination practice by . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.